436 related articles for article (PubMed ID: 30637550)
21. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
22. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
[TBL] [Abstract][Full Text] [Related]
24. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
[TBL] [Abstract][Full Text] [Related]
25. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
26. Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study.
Höppener DJ; Galjart B; Nierop PMH; Buisman FE; van der Stok EP; Coebergh van den Braak RRJ; van Amerongen MJ; Balachandran VP; Jarnagin WR; Kingham TP; Doukas M; Shia J; Nagtegaal ID; Vermeulen PB; Koerkamp BG; Grünhagen DJ; de Wilt JHW; D'Angelica MI; Verhoef C
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34056541
[TBL] [Abstract][Full Text] [Related]
27. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
28. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
[TBL] [Abstract][Full Text] [Related]
29. Local tumour control after radiofrequency or microwave ablation for colorectal liver metastases in relation to histopathological growth patterns.
Vles MD; Höppener DJ; Galjart B; Moelker A; Vermeulen PB; Grünhagen DJ; Verhoef C
HPB (Oxford); 2022 Sep; 24(9):1443-1452. PubMed ID: 35144863
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
[TBL] [Abstract][Full Text] [Related]
31. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
[TBL] [Abstract][Full Text] [Related]
32. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
Behrenbruch C; Prabhakaran S; Udayasiri D D; Michael M; Hollande F; Hayes I; Heriot AG; Knowles B; Thomson BN
J Surg Oncol; 2021 Apr; 123(5):1263-1273. PubMed ID: 33524184
[TBL] [Abstract][Full Text] [Related]
33. Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.
Siriwardana PN; Luong TV; Watkins J; Turley H; Ghazaley M; Gatter K; Harris AL; Hochhauser D; Davidson BR
Medicine (Baltimore); 2016 Feb; 95(8):e2924. PubMed ID: 26937938
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method.
Cheng J; Wei J; Tong T; Sheng W; Zhang Y; Han Y; Gu D; Hong N; Ye Y; Tian J; Wang Y
Ann Surg Oncol; 2019 Dec; 26(13):4587-4598. PubMed ID: 31605342
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
[TBL] [Abstract][Full Text] [Related]
37. A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
Balachandran VP; Arora A; Gönen M; Ito H; Turcotte S; Shia J; Viale A; Snoeren N; van Hooff SR; Rinkes IH; Adam R; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
Clin Cancer Res; 2016 May; 22(10):2575-82. PubMed ID: 26733613
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
39. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
40. Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma.
Meyer YM; Beumer BR; Höppener DJ; Nierop PMH; Doukas M; de Wilde RF; Sprengers D; Vermeulen PB; Verhoef C; IJzermans JNM
HPB (Oxford); 2022 Apr; 24(4):507-515. PubMed ID: 34393042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]